Skip to content

A Randomized, Double-Blind, Placebo-Controlled Crossover Study on the Effects of Foods Containing Fermented Plant Extracts on Bowel Movements and Intestinal Flora

A Randomized, Double-Blind, Placebo-Controlled Crossover Study on the Effects of Foods Containing Fermented Plant Extracts on Bowel Movements and Intestinal Flora - Effects of Foods Containing Fermented Plant Extracts on Bowel Movements and Intestinal Flora

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024111
Enrollment
20
Registered
2016-09-30
Start date
2016-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male and Female, aged 20-64 years Mild constipation (2-4 bowel movements per week) Hard stools, with pain during defecation Mild constipation that has been present for at least 6 months

Interventions

2weeks intake of foods containing fermented plant extracts , 4-weeks washout period,2weeks intake of foods no containing fermented plant extract (placebo), Intake three 580mg soft cupsel for 3 times p

Sponsors

Hokkaido Pharmaceutical University School of Pharmacy
Lead Sponsor
Oneness Support Co,.Ltd. Medical Corporation Kaonnkai Miura Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Male and Female, aged 20-64 years (2)Mild constipation (2-4 bowel movements per week) (3)Hard stools, with pain during defecation (4)Mild constipation that has been present for at least 6 months

Exclusion criteria

Exclusion criteria: (1) Individuals with a serious illness, such as diabetes, brain dysfunction, liver disease, kidney disease, heart disease, peripheral vascular disorders, and digestive system disease or those with a history of such illnesses (2) Individuals currently undergoing treatment for a disease (3) Individuals who have undergone surgery on the digestive tract (4) Individuals with food or drug allergies (5) Individuals routinely using medicinal agents, foods, beverages, or supplements thought to improve constipation (6) Individuals who drink an excessive amount of alcohol daily or who cannot abstain from alcohol on the day before the study (7) Individuals engaged in intense sports or dieting (8) Individuals who are pregnant or who plan to become pregnant or are breastfeeding during the trial period (9) Individuals who have participated in a clinical trial of an investigational drug or a long-term clinical study of a food or cosmetic product (excluding single-dose studies) within the past 4 weeks and individuals who are currently participating in a clinical study (10) Individuals judged as being ineligible to participate by the investigator

Design outcomes

Primary

MeasureTime frame
Number of bowel movements, amount of stool, VAS questionnaire

Secondary

MeasureTime frame
Type of intestinal bacterial flora (as determined by 16S rRNA PCR analysis), type of putrefaction products in feces,Blood test, Urine analysis

Countries

Japan

Contacts

Public ContactKoji Wakame

Hokkaido Pharmaceutical University School of Pharmacy Pharmacology

wakame-k@hokuytakudai.ac.jp011-676-8682

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026